ReGen III Provides Quarterly Business Update
ReGen III (OTCQB: ISRJF), a clean technology company focused on upcycling used motor oil into Group III base oils, has provided its Q2 2025 business update. The company has made significant progress in multiple areas, including strengthening its patent portfolio to 38 issued patents and successfully closing a $1.75 million private placement with 38% insider participation.
Key developments include the appointment of Brad Kotush as CFO and Liam Gallacher as Board Director. The company has intensified its focus on offtake partnerships and strategic investments, with plans to participate in several international industry conferences. Additionally, ReGen III's European patent now has legal effect in 18 European member states, and its Australian patent application has been accepted.
ReGen III (OTCQB: ISRJF), una società di tecnologie pulite specializzata nel riutilizzo dell'olio motore usato per produrre oli base di Gruppo III, ha fornito l'aggiornamento operativo per il secondo trimestre 2025. L'azienda ha registrato progressi rilevanti in diversi ambiti, tra cui il rafforzamento del portafoglio brevetti fino a 38 brevetti concessi e la conclusione con successo di un placement privato da 1,75 milioni di dollari con una partecipazione interna del 38%.
I principali sviluppi comprendono la nomina di Brad Kotush come CFO e di Liam Gallacher come membro del consiglio. L'azienda ha intensificato l'attenzione sulle partnership di offtake e sugli investimenti strategici, con l'intenzione di partecipare a varie conferenze internazionali del settore. Inoltre, il brevetto europeo di ReGen III ha effetto legale in 18 Stati membri europei e la domanda di brevetto australiana è stata accettata.
ReGen III (OTCQB: ISRJF), una empresa de tecnología limpia centrada en reciclar aceite de motor usado para obtener aceites base de Grupo III, ha presentado su actualización comercial del segundo trimestre de 2025. La compañía ha avanzado significativamente en varios frentes, incluyendo el refuerzo de su cartera de patentes hasta 38 patentes concedidas y el cierre exitoso de una colocación privada de 1,75 millones de dólares con una participación interna del 38%.
Los desarrollos clave incluyen el nombramiento de Brad Kotush como CFO y de Liam Gallacher como director del consejo. La empresa ha intensificado su enfoque en asociaciones de offtake e inversiones estratégicas, y planea participar en varias conferencias internacionales del sector. Además, la patente europea de ReGen III tiene efecto legal en 18 Estados miembros europeos y su solicitud de patente en Australia ha sido aceptada.
ReGen III (OTCQB: ISRJF)는 폐기된 자동차 오일을 그룹 III 베이스 오일로 업사이클링하는 친환경 기술 기업으로, 2025년 2분기 사업 업데이트를 발표했습니다. 회사는 승인된 특허 수를 38건으로 확대하고 내부자 38% 참여로 175만 달러의 사모 발행을 성공적으로 마무리하는 등 여러 분야에서 유의미한 진전을 이뤘습니다.
주요 사항으로는 브래드 코터시(Brad Kotush)를 CFO로 임명하고 리암 갤러허(Liam Gallacher)를 이사회 이사로 선임한 점이 포함됩니다. 회사는 오프테이크 파트너십과 전략적 투자에 대한 집중을 강화했으며, 여러 국제 업계 컨퍼런스에 참가할 계획입니다. 또한 ReGen III의 유럽 특허는 18개 유럽 회원국에서 법적 효력을 가지게 되었고, 호주 특허 출원은 수락되었습니다.
ReGen III (OTCQB: ISRJF), une entreprise de technologies propres spécialisée dans la valorisation de l'huile moteur usagée en huiles de base de Groupe III, a publié sa mise à jour commerciale pour le deuxième trimestre 2025. La société a réalisé des progrès significatifs dans plusieurs domaines, notamment le renforcement de son portefeuille de brevets à 38 brevets délivrés et la clôture réussie d'un placement privé de 1,75 million de dollars avec une participation interne de 38 %.
Parmi les développements clés figurent la nomination de Brad Kotush au poste de CFO et de Liam Gallacher au conseil d'administration. L'entreprise a intensifié son focus sur les partenariats d'offtake et les investissements stratégiques, et prévoit de participer à plusieurs conférences internationales du secteur. De plus, le brevet européen de ReGen III a désormais un effet juridique dans 18 États membres européens, et la demande de brevet australienne a été acceptée.
ReGen III (OTCQB: ISRJF), ein Clean-Tech-Unternehmen, das gebrauchtes Motoröl zu Group-III-Basisölen upcycelt, hat sein Geschäftsupdate für das zweite Quartal 2025 veröffentlicht. Das Unternehmen verzeichnete in mehreren Bereichen bedeutende Fortschritte, darunter die Stärkung seines Patentportfolios auf 38 erteilte Patente und den erfolgreichen Abschluss einer Privatplatzierung über 1,75 Millionen US-Dollar mit 38% Insiderbeteiligung.
Wesentliche Entwicklungen sind die Ernennung von Brad Kotush zum CFO und Liam Gallacher zum Vorstandsmitglied. Das Unternehmen hat seinen Schwerpunkt auf Abnahmevereinbarungen und strategische Investitionen verstärkt und plant die Teilnahme an mehreren internationalen Branchenkonferenzen. Zudem hat das europäische Patent von ReGen III in 18 europäischen Mitgliedstaaten rechtliche Wirkung erlangt und die australische Patentanmeldung wurde akzeptiert.
- Successfully closed $1.75M private placement with strong 38% insider participation
- Expanded patent portfolio to 38 issued patents, with legal effect in 18 European states
- Third-party product testing yielded results exceeding expectations
- Strengthened leadership team with new CFO and Board Director appointments
- None.
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - ReGen III Corp. (TSXV: GIII) (OTCQB: ISRJF) ("ReGen III" or the "Company"), a leading clean technology company specializing in the upcycling of used motor oil ("UMO") into high-value Group III base oils, is pleased to present its second quarter update, available in video here.
Key Highlights
Enhanced Commercial and Strategic Partnership Engagement
ReGen III has intensified its focus on offtake and strategic partnerships, which remain a top priority for management. The Company has engaged in numerous in-person meetings to advance offtake partnerships, strategic investments, and M&A opportunities, including valuable connections made at the ESF North America conference in Houston in June 2025.
Building on this momentum, the leadership team is set to travel internationally by invitation in the coming quarter and is scheduled to participate in the Independent Lubricant Manufacturers 2025 ILMA Annual Meeting, the 20th ICIS Middle Eastern Base Oils and Lubricants Conference in Dubai, UAE, and the 2025 ENFINITE Conference & Trade Show, a key event for North America's industrial liquid recyclers.
Intellectual Property and Technical Validation
Over the past several months, the Company hosted numerous technical meetings, with corresponding third-party product testing yielding results that surpassed expectations. In addition, following the issuance of the Company's patent by the European Patent Office ("EPO"), announced June 2, 2025, ReGen III's patent now has legal effect in 18 European member states. ReGen III has also been advised that its Australian patent application has been accepted by the Australian Patent Office, collectively bringing the Company's patent portfolio to 38 issued, two accepted, and ten (10) pending patents.
Leadership Enhancements
To support accelerated commercial and financing activities, ReGen III has strengthened its leadership team. Brad Kotush, an accomplished public-company CFO, joined as Chief Financial Officer in August 2025. Additionally, Liam Gallacher was appointed to the Board of Directors in April 2025.
Financing Achievements
On July 14, 2025, ReGen III successfully closed a
Investor Relations
In August 2025, ReGen III participated in the OTCQB Venture Virtual Investor Conference. In the coming quarter, the Company plans to launch a new website to further articulate its vision, showcase its sustainable technology, and streamline investor relations processes.
CEO Commentary
"Over the past four months, we have experienced a significant acceleration in our offtake and strategic investment discussions," stated Tony Weatherill, President & CEO of ReGen III. "Interest in our transformative project and sustainable product suite continues to grow, and we expect the coming quarter to be highly productive. As we advance strategic conversations and execute on this exciting phase of our growth, I am delighted to have our new CFO, Brad Kotush, onboard. Brad's wealth of experience in capital markets and corporate scaling will be invaluable as we solidify partnerships."
For more insights into ReGen III's strategic direction and ongoing initiatives, Tony Weatherill's investor presentation is available here.
About ReGen III
ReGen III Corp. is driving a new era in high performance, sustainable lubricants. Harnessing its patented ReGen™ technology, the Company is commercializing an advanced process to transform used motor oil ("UMO") into premium Group II and III base oils. These high-quality base oils are essential to high performance engines, turbines, and industrial applications - and ReGen III's process is designed to deliver up to
With FEL2 and value engineering complete for its proposed 5,600 bpd flagship facility in Texas City, Texas - and backed by worldclass engineering, construction, and vendor partners - the Company is strategically positioned to meet rising demand for higher quality, circular base oils. In addition to Texas City, the Company is evaluating opportunities to deploy its patented technology across other strategic markets.
With the vision of becoming the world's largest producer of sustainable, re-refined Group III base oils, ReGen III aims to set a new standard for performance and responsibility in the global lubricants market.
For more information on ReGen III or to subscribe to the Company's mailing list, please visit: www.regeniii.com/investors/corporate-presentations and www.regeniii.com/newsletter-subscription.
For further information, please contact:
Investor & Media inquiries:
Email: investors@regeniii.com
Corporate Inquiries:
Kimberly Hedlin
Vice President, Corporate Finance
Tel: (403) 921-9012
Email: info@regeniii.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Certain information other than statements of historical facts contained in this news release constitutes "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information"). Without limiting the foregoing, such forward-looking information includes statements regarding the Company's business plans, expectations, capital costs and objectives. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking information. Forward-looking information should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. Forward-looking information is based on information available at the time and/or the Company management's good faith belief with respect to future events and is subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond the Company's control. For additional information with respect to these and other factors and assumptions underlying the forward-looking information made in this news release, see the Company's most recent Management's Discussion and Analysis and financial statements and other documents filed by the Company with the Canadian securities commissions and the discussion of risk factors set out therein. Such documents are available at www.sedarplus.ca under the Company's profile and on the Company's website, www.ReGenIII.com. The forward-looking information set forth herein reflects the Company's expectations as at the date of this news release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/264919
FAQ
What was the size of ReGen III's (ISRJF) recent private placement in 2025?
How many patents does ReGen III (ISRJF) currently hold?
Who are the new key appointments at ReGen III (ISRJF) in 2025?
What upcoming conferences will ReGen III (ISRJF) attend in 2025?
What is ReGen III's (ISRJF) main business focus?
